Seeing Is Believing
Currently out of the existing stock ratings of Brian Tanquilut, 160 are a BUY (73.73%), 51 are a HOLD (23.5%), 6 are a SELL (2.76%).
Analyst Brian Tanquilut, currently employed at JEFFERIES, carries an average stock price target met ratio of 58.22% that have a potential upside of 18.47% achieved within 253 days.
Brian Tanquilut’s has documented 439 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DGX, Quest Diagnostics orporated at 10-Dec-2024.
Analyst best performing recommendations are on MCK (MCKESSON).
The best stock recommendation documented was for MD (MEDNAX) at 11/11/2013. The price target of $62.5 was fulfilled within 39 days with a profit of $46.37 (42.59%) receiving and performance score of 10.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$215
$40.04 (22.89%)
$187
1 years 4 months 10 days ago
(07-Aug-2023)
14/15 (93.33%)
$28.91 (15.54%)
667
Hold
$190
$15.04 (8.60%)
$176
1 years 4 months 14 days ago
(03-Aug-2023)
7/7 (100%)
$-0.86 (-0.45%)
477
Buy
$220
$45.04 (25.74%)
$213
1 years 4 months 14 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
1 years 4 months 14 days ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
1 years 4 months 16 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Brian Tanquilut is most bullish on?
Which stock is Brian Tanquilut is most reserved on?
What Year was the first public recommendation made by Brian Tanquilut?